A detailed history of Summitry LLC transactions in Pfizer Inc stock. As of the latest transaction made, Summitry LLC holds 21,008 shares of PFE stock, worth $526,880. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,008
Previous 8,953 134.65%
Holding current value
$526,880
Previous $217,000 146.54%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$23.29 - $25.88 $280,760 - $311,983
12,055 Added 134.65%
21,008 $535,000
Q2 2025

Aug 08, 2025

BUY
$21.59 - $24.84 $193,295 - $222,392
8,953 New
8,953 $217,000
Q4 2024

Feb 11, 2025

BUY
$24.8 - $30.19 $213,156 - $259,483
8,595 New
8,595 $228,000
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $162,641 - $201,532
-3,555 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $146,892 - $217,743
3,555 New
3,555 $210,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Summitry LLC Portfolio

Follow Summitry LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summitry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summitry LLC with notifications on news.